-
Mashup Score: 0The state of care for patients with overactive bladder - 11 month(s) ago
“It’s certainly a bigger problem with advancing age in the geriatric population, and it can be a tremendous source of cost for patients who have these issues,” says Gina M. Rooker, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet
-
Mashup Score: 0Wolters Kluwer Health - 11 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, OBGYNTweet-
.@tajiurogyn et al. find diabetic patients had a similar rate of urinary retention requiring CIC after BoNT injection for #OAB compared with nondiabetic patients. @SHandlerMD @KatharinaLaus @sarah_eckhardt @HarborUCLA https://t.co/4bMWFwlmE7
-
-
Mashup Score: 0Wolters Kluwer Health - 11 month(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, OBGYNTweet-
Despite known link to dementia, anticholinergic medications account for the majority of prescriptions to treat overactive bladder in the United States #OAB @MountAuburnHosp @BIDMChealth @harvardmed @NIH https://t.co/Or2ErL9opV
-
-
Mashup Score: 0Phase 2a Trial Results: Promising Gene Therapy for Overactive Bladder - URO-902 Safety and Efficacy Evaluation - Kenneth Peters - 11 month(s) ago
Ken Peters joins Diane Newman to present the results of a Phase 2a trial evaluating the safety and efficacy of URO-902, an investigational gene therapy for overactive bladder. URO-902 is a plasma vector that expresses the alpha subunit of the human BK channel, which reduces bladder overactivity and leads to detrusor relaxation. The trial included women between 40 and 70 years old with urgency…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Phase 2a trial results: Promising gene therapy for #OveractiveBladder - URO-902 safety and efficacy evaluation. @KennethMPeters1 @BeaumontUrology and @DrDianeNewman discuss these results on UroToday > https://t.co/czCJwVimMM @urovant #OAB #BladderHealth https://t.co/Ph7h0D3s6A
-
-
Mashup Score: 0Dr. Sheyn on the use of Axonics therapy for bladder/bowel dysfunction - 12 month(s) ago
“The improvement is sustained, but over time it does tend to decrease and we’re currently trying to figure out why,” says David Sheyn, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Dr. David Sheyn discusses the use of Axonics therapy for bladder/bowel dysfunction. #urology #urologist #OAB @CaseUrology Watch now: https://t.co/ozYVdEAv3f
-
-
Mashup Score: 3Removal of sacral neuromodulation devices in office found to be safe and efficacious - 1 year(s) ago
“This is something [that is] a lot easier for the patient, it’s a lot less costly to the health care system to stay out of the operating room, and it’s a lot quicker for me,” says Howard B. Goldman, MD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Removal of sacral neuromodulation devices in office found to be safe and efficacious. #urology #urologist #OAB #overactivebladder @CleClinicUro Read more: https://t.co/zXmAzPM9EL
-
-
Mashup Score: 0
Melissa A. Laudano, MD, highlights 3 studies in overactive bladder/incontinence being presented at the 2023 American Urological Association Annual Meeting.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Dr. Melissa A. Laudano highlights 3 studies in overactive bladder/incontinence that will be presented at #AUA23. #urology #urologist #OAB @MontefioreUro Watch now: https://t.co/GIU64V7PdA
-
-
Mashup Score: 0How step therapy for overactive bladder affects care quality - 1 year(s) ago
“The sad thing is that with something like OAB, we already have so many barriers to getting patients in to initiate care in the first place,” says A. Lenore Ackerman, MD, PhD.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
Dr. A. Lenore Ackerman discusses how step therapy for overactive bladder affects care quality. #urology #urologist #OAB @UclaUrology Read more: https://t.co/hW1WmgFCPa
-
-
Mashup Score: 0
The safety and efficacy of the Vivally System were established in the FREEOAB study, a prospective multi-center clinical trial that included 96 patients with overactive bladder.
Source: Urology TimesCategories: Latest Headlines, UrologyTweet-
#ICYMI: The FDA has granted 510(k) clearance to the Vivally System for overactive bladder. #urology #urologist #OAB Read more: https://t.co/d3xikrdT4d
-
-
Mashup Score: 2Wolters Kluwer Health - 1 year(s) ago
JavaScript Error JavaScript has been disabled on your browser. You must enable it to continue. Here’s how to enable JavaScript in the following browsers: Internet Explorer From the Tools menu, select Options Click the Content tab Select Enable JavaScript Firefox From the Tools…
Source: lww.comCategories: Latest Headlines, OBGYNTweet-
Vibegron, a β3-adrenergic receptor agonist, significantly improved symptoms in women with #OAB vs placebo and was safe/well tolerated in this subgroup analysis of women from the 12-week EMPOWUR trial. @PennMedicine @urovant #overactivebladder https://t.co/hQ4fj5df7c
-
Dr. Gina M. Rooker describes the state of care for patients with overactive bladder. #urology #urologist #OAB @AHNtoday Read here: https://t.co/7KjEHPZ774